Abstract:Background: Folate deficiency is an independent risk factor for congenital heart disease (CHD); however, the maternal plasma folate level is paradoxically not a good diagnostic marker. Genome-wide surveys have identified variants of nonfolate metabolic genes associated with the plasma folate level, suggesting that these genetic polymorphisms are potential risk factors for CHD. Methods: To examine the effects of folate concentration-related variations on CHD risk in the Han Chinese population, we performed 3 independent case-control studies including a total of 1489 patients with CHD and 1745 control subjects. The expression of the Fidgetin (FIGN) was detected in human cardiovascular and decidua tissue specimens with quantitative real-time polymerase chain reaction and Western blotting. The molecular mechanisms were investigated by luciferase reporter assays, surface plasmon resonance, and chromatin immunoprecipitation. FIGN-interacting proteins were confirmed by tandem affinity purification and coimmunoprecipitation. Proteasome activity and metabolite concentrations in the folate pathway were quantified with a commercial proteasome activity assay and immunoassays, respectively. Results: The +94762G>C (rs2119289) variant in intron 4 of the FIGN gene was associated with significant reduction in CHD susceptibility (P=5.1×10-14 for the allele, P=8.5×10--13 for the genotype). Analysis of combined samples indicated that CHD risks in individuals carrying heterozygous (GC) or homozygous (CC) genotypes were reduced by 44% (odds ratio [OR]=0.56; 95% confidence interval [CI]=0.47-0.67) and 66% (OR=0.34; 95% CI=0.23-0.50), respectively, compared with those with the major GG genotype. Minor C allele carriers who had decreased plasma folate levels exhibited significantly increased FIGN expression because the transcription suppressor CREB1 did not bind the alternative promoter of FIGN isoform X3. Mechanistically, increased FIGN expression led to the accumulation of both reduced folate carrier 1 and dihydrofolate reductase via inhibition of their proteasomal degradation, which promoted folate absorption and metabolism. Conclusions: We report a previously undocumented finding that decreased circulating folate levels induced by increased folate transmembrane transport and utilization, as determined by the FIGN intronic variant, serves as a protective mechanism against CHD. Our results may explain why circulating folate levels do not have a good diagnostic value.

Association of Snps in Genes Involved in Folate Metabolism with the Risk of Congenital Heart Disease

Mthfr C677t Polymorphism And Risk Of Congenital Heart Defects: Evidence From 29 Case-Control And Tdt Studies

Association of fetal congenital heart diseases with methylenetetrahydrofolate reductase gene polymorphisms

Correlation Between Rs198388 and Rs198389 Polymorphismsin Brainnatriuretic Peptide (NPPB) Gene and Susceptibility to Congenital Heart Diseases in a Chinese Population.

Association of methylenetetrahydrofolate reductase gene polymorphisms and maternal folic acid use with the risk of congenital heart disease

Methylenetetrahydrofolate reductase C677T and reduced folate carrier 80 G>A polymorphisms are associated with an increased risk of conotruncal heart defects

Association of Genetic Polymorphisms of De Novo Nucleotide Biosynthesis with Increased Chd Susceptibility in the Northern Chinese Population

Association between MTHFD1 G1958A polymorphism and neural tube defects susceptibility: a meta-analysis.

Association of maternal methionine synthase reductase gene polymorphisms with the risk of congenital heart disease in offspring: a hospital-based case-control study

Mthfr Rs1801133 C > T Polymorphism Is Associated With An Increased Risk Of Tetralogy Of Fallot

Association of Maternal Folate Intake and Offspring MTHFD1 and MTHFD2 Genes with Congenital Heart Disease

Association of Main Folate Metabolic Pathway Gene Polymorphisms with Neural Tube Defects in Han Population of Northern China

Association Between Single Nucleotide Polymorphisms of Folate Metabolism Pathway Genes and Neural Tube Defects in Children

[Study of serum Hcy and polymorphisms of Hcy metabolic enzymes in 192 families affected by congenital heart disease].

Association Between SNPs in Genes Involved in Folate Metabolism and Preterm Birth Risk

Relationship Between Polymorphism of Methylenetetrahydrofolate Dehydrogenase and Congenital Heart Defect.

Association Between Mthfr Polymorphisms and Congenital Heart Disease: A Meta-Analysis Based on 9,329 Cases and 15,076 Controls

Study on the Association Between Reduced Folate Carrier Gene Polymorphism and Congenital Heart Defects and Cleft Lip with or Without Cleft Palate

Lower Circulating Folate Induced by a Fidgetin Intronic Variant Is Associated With Reduced Congenital Heart Disease Susceptibility

Meta Analysis of the Association Between MTHFR C677T Polymorphism and the Risk of Congenital Heart Defects.

Association Between the Polymorphism of Methylenetetrahydrofolate Reductase Gene C 677 T and Risks of Congenital Heart Disease : Meta-analysis of Case-control Study